Mandate

Vinge advises UBS in connection with base prospectus regarding certificates and warrants

August 28, 2013

Vinge has advised UBS Deutschland AG in connection with the preparation of a three part base prospectus for structured products which will consist of various types of certificates and warrants. The structured products will primarily be traded on NASDAQ OMX Stockholm and possibly other Nordic exchanges. The base prospectus was approved by the Swedish Financial Supervisory Authority on 16 August 2013.

Vinge’s team consisted of responsible partner Anders Strid and lawyer Yohanna Öhrnegård.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026